183 related articles for article (PubMed ID: 20686129)
1. Mice producing less reactive oxygen species are relatively resistant to collagen glycopeptide vaccination against arthritis.
Batsalova T; Dzhambazov B; Klaczkowska D; Holmdahl R
J Immunol; 2010 Sep; 185(5):2701-9. PubMed ID: 20686129
[TBL] [Abstract][Full Text] [Related]
2. CD68-expressing cells can prime T cells and initiate autoimmune arthritis in the absence of reactive oxygen species.
Pizzolla A; Gelderman KA; Hultqvist M; Vestberg M; Gustafsson K; Mattsson R; Holmdahl R
Eur J Immunol; 2011 Feb; 41(2):403-12. PubMed ID: 21268010
[TBL] [Abstract][Full Text] [Related]
3. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene.
Hultqvist M; Olofsson P; Holmberg J; Bäckström BT; Tordsson J; Holmdahl R
Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12646-51. PubMed ID: 15310853
[TBL] [Abstract][Full Text] [Related]
4. Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen-induced arthritis.
Bäcklund J; Treschow A; Bockermann R; Holm B; Holm L; Issazadeh-Navikas S; Kihlberg J; Holmdahl R
Eur J Immunol; 2002 Dec; 32(12):3776-84. PubMed ID: 12516572
[TBL] [Abstract][Full Text] [Related]
5. Breaking T cell tolerance against self type II collagen in HLA-DR4-transgenic mice and development of autoimmune arthritis.
Batsalova T; Dzhambazov B; Merky P; Bäcklund A; Bäcklund J
Arthritis Rheum; 2010 Jul; 62(7):1911-20. PubMed ID: 20309862
[TBL] [Abstract][Full Text] [Related]
6. Lack of reactive oxygen species breaks T cell tolerance to collagen type II and allows development of arthritis in mice.
Hultqvist M; Bäcklund J; Bauer K; Gelderman KA; Holmdahl R
J Immunol; 2007 Aug; 179(3):1431-7. PubMed ID: 17641008
[TBL] [Abstract][Full Text] [Related]
7. Genetic control of tolerance to type II collagen and development of arthritis in an autologous collagen-induced arthritis model.
Bäcklund J; Nandakumar KS; Bockermann R; Mori L; Holmdahl R
J Immunol; 2003 Oct; 171(7):3493-9. PubMed ID: 14500645
[TBL] [Abstract][Full Text] [Related]
8. A dominant suppressive MHC class II haplotype interacting with autosomal genes controls autoantibody production and chronicity of arthritis.
Nandakumar KS; Lindqvist AK; Holmdahl R
Ann Rheum Dis; 2011 Sep; 70(9):1664-70. PubMed ID: 21613311
[TBL] [Abstract][Full Text] [Related]
9. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells.
Nandakumar KS; Bäcklund J; Vestberg M; Holmdahl R
Arthritis Res Ther; 2004; 6(6):R544-50. PubMed ID: 15535832
[TBL] [Abstract][Full Text] [Related]
10. Antigen-induced, tolerogenic CD11c+,CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis.
Min SY; Park KS; Cho ML; Kang JW; Cho YG; Hwang SY; Park MJ; Yoon CH; Min JK; Lee SH; Park SH; Kim HY
Arthritis Rheum; 2006 Mar; 54(3):887-98. PubMed ID: 16508971
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
12. Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis.
Bäcklund J; Carlsen S; Höger T; Holm B; Fugger L; Kihlberg J; Burkhardt H; Holmdahl R
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9960-5. PubMed ID: 12089323
[TBL] [Abstract][Full Text] [Related]
13. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
Zhou F; He X; Iwakura Y; Horai R; Stuart JM
Arthritis Rheum; 2005 Dec; 52(12):3731-8. PubMed ID: 16320323
[TBL] [Abstract][Full Text] [Related]
14. The influence of HLA-DR4 (0401) on the immune response to type II collagen and the development of collagen induced arthritis in mice.
Wang D; Hill JA; Cairns E; Bell DA
J Autoimmun; 2002 Mar; 18(2):95-103. PubMed ID: 11908942
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of collagen type II-specific immune responses during development of collagen-induced arthritis in two B10 mouse strains.
Batsalova T; Lindh I; Bäcklund J; Dzhambazov B; Holmdahl R
Arthritis Res Ther; 2012 Nov; 14(6):R237. PubMed ID: 23116329
[TBL] [Abstract][Full Text] [Related]
16. Identification of the minimal glycopeptide core recognized by T cells in a model for rheumatoid arthritis.
Holm L; Kjellén P; Holmdahl R; Kihlberg J
Bioorg Med Chem; 2005 Jan; 13(2):473-82. PubMed ID: 15598569
[TBL] [Abstract][Full Text] [Related]
17. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with an immunodominant peptide of bovine type II collagen induces an anti-TCR response, and modulates the onset and severity of collagen-induced arthritis.
Honda A; Ametani A; Matsumoto T; Iwaya A; Kano H; Hachimura S; Ohkawa K; Kaminogawa S; Suzuki K; Sercarz EE; Kumar V
Int Immunol; 2004 May; 16(5):737-45. PubMed ID: 15096482
[TBL] [Abstract][Full Text] [Related]
19. Th17 development and autoimmune arthritis in the absence of reactive oxygen species.
George-Chandy A; Nordström I; Nygren E; Jonsson IM; Postigo J; Collins LV; Eriksson K
Eur J Immunol; 2008 Apr; 38(4):1118-26. PubMed ID: 18383034
[TBL] [Abstract][Full Text] [Related]
20. Reversal of tolerance induced by transplantation of skin expressing the immunodominant T cell epitope of rat type II collagen entitles development of collagen-induced arthritis but not graft rejection.
Bäcklund J; Treschow A; Firan M; Malmström V; Issazadeh-Navikas S; Ward ES; Holmdahl R
Eur J Immunol; 2002 Jun; 32(6):1773-83. PubMed ID: 12115661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
